Selected research
Industry Research
Grosvenorine Industry Research Report 2026
Market perspective
The global Grosvenorine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Grosvenorine is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Grosvenorine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Grosvenorine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Grosvenorine include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Grosvenorine market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Grosvenorine.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Grosvenorine Market by Company
Adooq Bioscience
Biorbyt
MedChemExpress
Sigma-Aldrich
Smolecule
TargetMol Chemicals
Chengdu Push Bio-technology
Nanjingpuyi
Winherb
Shanghai yuanye Bio-Technology
Chengdu Biopurify Phytochemicals
Jiangsu Yongjian Pharmaceutical
BioBioPha
Chengdu Caoyuankang Bio-technology
Grosvenorine Segment by Type
Above 98%
Below 98%
Grosvenorine Segment by Application
Scientific Research
Pharmaceutical
Natural Colouring
Grosvenorine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Grosvenorine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Grosvenorine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Grosvenorine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Grosvenorine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Grosvenorine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Grosvenorine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Below 98%
Applications
- Scientific Research
- Pharmaceutical
- Natural Colouring
Companies covered
- Adooq Bioscience
- Biorbyt
- MedChemExpress
- Sigma-Aldrich
- Smolecule
- TargetMol Chemicals
- Chengdu Push Bio-technology
- Nanjingpuyi
- Winherb
- Shanghai yuanye Bio-Technology
- Chengdu Biopurify Phytochemicals
- Jiangsu Yongjian Pharmaceutical
- BioBioPha
- Chengdu Caoyuankang Bio-technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Grosvenorine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Above 98%
- 2.2.3 Below 98%
- 2.3 Grosvenorine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Scientific Research
- 2.3.3 Pharmaceutical
- 2.3.4 Natural Colouring
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Grosvenorine Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Grosvenorine Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Grosvenorine Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Grosvenorine Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Grosvenorine Production by Manufacturers (2021-2026)
- 3.2 Global Grosvenorine Production Value by Manufacturers (2021-2026)
- 3.3 Global Grosvenorine Average Price by Manufacturers (2021-2026)
- 3.4 Global Grosvenorine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Grosvenorine Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Grosvenorine Manufacturers, Product Type & Application
- 3.7 Global Grosvenorine Manufacturers Established Date
- 3.8 Global Grosvenorine Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Adooq Bioscience
- 4.1.1 Adooq Bioscience Grosvenorine Company Information
- 4.1.2 Adooq Bioscience Grosvenorine Business Overview
- 4.1.3 Adooq Bioscience Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Adooq Bioscience Product Portfolio
- 4.1.5 Adooq Bioscience Recent Developments
- 4.2 Biorbyt
- 4.2.1 Biorbyt Grosvenorine Company Information
- 4.2.2 Biorbyt Grosvenorine Business Overview
- 4.2.3 Biorbyt Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Biorbyt Product Portfolio
- 4.2.5 Biorbyt Recent Developments
- 4.3 MedChemExpress
- 4.3.1 MedChemExpress Grosvenorine Company Information
- 4.3.2 MedChemExpress Grosvenorine Business Overview
- 4.3.3 MedChemExpress Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 MedChemExpress Product Portfolio
- 4.3.5 MedChemExpress Recent Developments
- 4.4 Sigma-Aldrich
- 4.4.1 Sigma-Aldrich Grosvenorine Company Information
- 4.4.2 Sigma-Aldrich Grosvenorine Business Overview
- 4.4.3 Sigma-Aldrich Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sigma-Aldrich Product Portfolio
- 4.4.5 Sigma-Aldrich Recent Developments
- 4.5 Smolecule
- 4.5.1 Smolecule Grosvenorine Company Information
- 4.5.2 Smolecule Grosvenorine Business Overview
- 4.5.3 Smolecule Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Smolecule Product Portfolio
- 4.5.5 Smolecule Recent Developments
- 4.6 TargetMol Chemicals
- 4.6.1 TargetMol Chemicals Grosvenorine Company Information
- 4.6.2 TargetMol Chemicals Grosvenorine Business Overview
- 4.6.3 TargetMol Chemicals Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 TargetMol Chemicals Product Portfolio
- 4.6.5 TargetMol Chemicals Recent Developments
- 4.7 Chengdu Push Bio-technology
- 4.7.1 Chengdu Push Bio-technology Grosvenorine Company Information
- 4.7.2 Chengdu Push Bio-technology Grosvenorine Business Overview
- 4.7.3 Chengdu Push Bio-technology Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Chengdu Push Bio-technology Product Portfolio
- 4.7.5 Chengdu Push Bio-technology Recent Developments
- 4.8 Nanjingpuyi
- 4.8.1 Nanjingpuyi Grosvenorine Company Information
- 4.8.2 Nanjingpuyi Grosvenorine Business Overview
- 4.8.3 Nanjingpuyi Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Nanjingpuyi Product Portfolio
- 4.8.5 Nanjingpuyi Recent Developments
- 4.9 Winherb
- 4.9.1 Winherb Grosvenorine Company Information
- 4.9.2 Winherb Grosvenorine Business Overview
- 4.9.3 Winherb Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Winherb Product Portfolio
- 4.9.5 Winherb Recent Developments
- 4.10 Shanghai yuanye Bio-Technology
- 4.10.1 Shanghai yuanye Bio-Technology Grosvenorine Company Information
- 4.10.2 Shanghai yuanye Bio-Technology Grosvenorine Business Overview
- 4.10.3 Shanghai yuanye Bio-Technology Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Shanghai yuanye Bio-Technology Product Portfolio
- 4.10.5 Shanghai yuanye Bio-Technology Recent Developments
- 4.11 Chengdu Biopurify Phytochemicals
- 4.11.1 Chengdu Biopurify Phytochemicals Grosvenorine Company Information
- 4.11.2 Chengdu Biopurify Phytochemicals Grosvenorine Business Overview
- 4.11.3 Chengdu Biopurify Phytochemicals Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Chengdu Biopurify Phytochemicals Product Portfolio
- 4.11.5 Chengdu Biopurify Phytochemicals Recent Developments
- 4.12 Jiangsu Yongjian Pharmaceutical
- 4.12.1 Jiangsu Yongjian Pharmaceutical Grosvenorine Company Information
- 4.12.2 Jiangsu Yongjian Pharmaceutical Grosvenorine Business Overview
- 4.12.3 Jiangsu Yongjian Pharmaceutical Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Yongjian Pharmaceutical Product Portfolio
- 4.12.5 Jiangsu Yongjian Pharmaceutical Recent Developments
- 4.13 BioBioPha
- 4.13.1 BioBioPha Grosvenorine Company Information
- 4.13.2 BioBioPha Grosvenorine Business Overview
- 4.13.3 BioBioPha Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 BioBioPha Product Portfolio
- 4.13.5 BioBioPha Recent Developments
- 4.14 Chengdu Caoyuankang Bio-technology
- 4.14.1 Chengdu Caoyuankang Bio-technology Grosvenorine Company Information
- 4.14.2 Chengdu Caoyuankang Bio-technology Grosvenorine Business Overview
- 4.14.3 Chengdu Caoyuankang Bio-technology Grosvenorine Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Chengdu Caoyuankang Bio-technology Product Portfolio
- 4.14.5 Chengdu Caoyuankang Bio-technology Recent Developments
5 Global Grosvenorine Production by Region
- 5.1 Global Grosvenorine Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Grosvenorine Production by Region: 2021-2032
- 5.2.1 Global Grosvenorine Production by Region: 2021-2026
- 5.2.2 Global Grosvenorine Production Forecast by Region (2027-2032)
- 5.3 Global Grosvenorine Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Grosvenorine Production Value by Region: 2021-2032
- 5.4.1 Global Grosvenorine Production Value by Region: 2021-2026
- 5.4.2 Global Grosvenorine Production Value Forecast by Region (2027-2032)
- 5.5 Global Grosvenorine Market Price Analysis by Region (2021-2026)
- 5.6 Global Grosvenorine Production and Value, YOY Growth
- 5.6.1 North America Grosvenorine Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Grosvenorine Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Grosvenorine Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Grosvenorine Production Value Estimates and Forecasts (2021-2032)
6 Global Grosvenorine Consumption by Region
- 6.1 Global Grosvenorine Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Grosvenorine Consumption by Region (2021-2032)
- 6.2.1 Global Grosvenorine Consumption by Region: 2021-2026
- 6.2.2 Global Grosvenorine Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Grosvenorine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Grosvenorine Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Grosvenorine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Grosvenorine Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Grosvenorine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Grosvenorine Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Grosvenorine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Grosvenorine Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Grosvenorine Production by Type (2021-2032)
- 7.1.1 Global Grosvenorine Production by Type (2021-2032) & (Kg)
- 7.1.2 Global Grosvenorine Production Market Share by Type (2021-2032)
- 7.2 Global Grosvenorine Production Value by Type (2021-2032)
- 7.2.1 Global Grosvenorine Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Grosvenorine Production Value Market Share by Type (2021-2032)
- 7.3 Global Grosvenorine Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Grosvenorine Production by Application (2021-2032)
- 8.1.1 Global Grosvenorine Production by Application (2021-2032) & (Kg)
- 8.1.2 Global Grosvenorine Production Market Share by Application (2021-2032)
- 8.2 Global Grosvenorine Production Value by Application (2021-2032)
- 8.2.1 Global Grosvenorine Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Grosvenorine Production Value Market Share by Application (2021-2032)
- 8.3 Global Grosvenorine Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Grosvenorine Value Chain Analysis
- 9.1.1 Grosvenorine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Grosvenorine Production Mode & Process
- 9.2 Grosvenorine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Grosvenorine Distributors
- 9.2.3 Grosvenorine Customers
10 Global Grosvenorine Analyzing Market Dynamics
- 10.1 Grosvenorine Industry Trends
- 10.2 Grosvenorine Industry Drivers
- 10.3 Grosvenorine Industry Opportunities and Challenges
- 10.4 Grosvenorine Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst